List view / Grid view

The Institute of Cancer Research

 

Gene activity linked to breast cancer survival

18 August 2016 | By The Institute of Cancer Research, London

In a study of nearly 2000 patients, researchers found that women whose tumours had high F12 activity and low STC2 activity had a 32% chance of dying within 10 years, whereas those with low F12 activity and high STC2 activity had only a 10% chance of dying...

Lapatinib and trastuzumab shrinks HER2+ breast cancers within 11 days

11 March 2016 | By Victoria White

A trial has shown that lapatinib plus trastuzumab before surgery shrinks and may even destroy tumours in women with HER2+ breast cancer within 11 days. The EPHOS B trial studied 257 women with HER2 positive breast cancer in the short gap between initial diagnosis and surgery to remove their tumours.…

Send this to a friend